• Episurf Medical's subsidiary Frusipe Intressenter Target 1 will retain SEK 332.5 million nominal value of bonds issued by Ilija Batljan Invest.
• The board withdrew its proposal to approve the subsidiary's acceptance of a contemplated tender offer from the November 12, 2026, extraordinary meeting.
• The board considers retaining the bonds more advantageous for shareholders than accepting the offer on the available terms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Episurf Medical AB published the original content used to generate this news brief via Cision (Ref. ID: 202610300800BITN____UKPR__EN_20261030-BIT-2486-0) on October 30, 2026, and is solely responsible for the information contained therein.